Windtree Therapeutics (Nasdaq: WINT) Makes NASDAQ Top Gainers List on News of Istaroxime Clinical Development and Upcoming Clinical Trial Data

Windtree Therapeutics (Nasdaq: WINT) Makes NASDAQ Top Gainers List on News of Istaroxime Clinical Development and Upcoming Clinical Trial Data: Windtree Therapeutics (Nasdaq: WINT) Makes NASDAQ Top Gainers List on News of Istaroxime Clinical Development and Upcoming Clinical Trial Data